Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC

Fig. 5

Kaplan-Meier curves for RFS in differernt groups of patients from validation cohort. a Patients of low APE1 expression and low CD4+ T cells infiltration compared with patients of low APE1 expression and high CD4+ T cells infiltration. b Patients of high APE1 expression and low CD4+ T cells infiltration compared with patients of high APE1 expression and high CD4+ T cells infiltration. c Patients of high APE1 expression and low CD4+ T cells infiltration compared with patients of low APE1 expression and high CD4+ T cells infiltration. d Patients of low CD4+ T cells infiltration and low APE1 expression compared with patients of low CD4+ T cells infiltration and high APE1 expression. e Patients of high CD4+ T cells infiltration and low APE1 expression compared with patients of high CD4+ T cells infiltration and high APE1 expression. f Patients of low APE1 expression and low CD4+ T cells infiltration compared with patients of high APE1 expression and high CD4+ T cells infiltration

Back to article page